Improved procedural workflow for catheter ablation of paroxysmal AF with high-density mapping system and advanced technology: Rationale and study design of a multicenter international study.
Francesco SolimeneGiuseppe StabilePablo RamosLuca SegretiFilippo Maria CautiValerio De SanctisRuggero MaggioJavier Ramos-MaquedaLluis MontVincenzo SchillaciMaurizio MalacridaIgnacio Garcia-BolaoPublished in: Clinical cardiology (2022)
The DELETE AF trial will provide additional knowledge on long-term outcome following a structured ablation workflow, with high density mapping, advanced algorithms and local impedance technology, in an international multicentric fashion. DELETE AF is registered at ClinicalTrials.gov (NCT05005143).